This topic contains a solution. Click here to go to the answer

Author Question: A perfectly competitive firm in the short-run can earn: a. positive economic profits. b. negative ... (Read 146 times)

arivle123

  • Hero Member
  • *****
  • Posts: 569
A perfectly competitive firm in the short-run can earn:
 a. positive economic profits.
  b. negative economic profits.
  c. zero economic profits.
  d. all of these are possible

Question 2

If a consumer's purchases of a product increases as income increases, this good is classified as a(n):
 a. superior good.
  b. inferior good.
  c. substitute good.
  d. complementary good.
  e. normal good.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

emily12345

  • Sr. Member
  • ****
  • Posts: 321
Answer to Question 1

d

Answer to Question 2

e




arivle123

  • Member
  • Posts: 569
Reply 2 on: Jun 30, 2018
YES! Correct, THANKS for helping me on my review


dawsa925

  • Member
  • Posts: 326
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

The most common childhood diseases include croup, chickenpox, ear infections, flu, pneumonia, ringworm, respiratory syncytial virus, scabies, head lice, and asthma.

Did you know?

There are 20 feet of blood vessels in each square inch of human skin.

Did you know?

People with alcoholism are at a much greater risk of malnutrition than are other people and usually exhibit low levels of most vitamins (especially folic acid). This is because alcohol often takes the place of 50% of their daily intake of calories, with little nutritional value contained in it.

Did you know?

Signs of depression include feeling sad most of the time for 2 weeks or longer; loss of interest in things normally enjoyed; lack of energy; sleep and appetite disturbances; weight changes; feelings of hopelessness, helplessness, or worthlessness; an inability to make decisions; and thoughts of death and suicide.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library